go to the Content

Assistive Product M-neb pressure +

Product Type

Ultrasonic nebulizer

Description

M-neb pressure is a mesh nebulizer for aerosol drug delivery close to the patient. High-frequency pulses convey small quantities of the liquid medication through a special membrane. Its microstructure channels the droplet formation and guarantees that only droplets less than four micrometres in diameter are delivered. The medication is transported gently through the Micro-Mesh-Driver and is not heated. The small droplets can penetrate via the bronchial tree to the alveoli and thus directly to the site of action.

Features / Components

  • has two nebulization modes: continuous mode (for permanent nebulization) or triggered mode (for inspiration-synchronized nebulization)
  • automatic switch-off
  • one hour running time ( continuous mode)
  • two hours running time (triggered mode)
  • can be used with or without a ventilator
  • inspiratory flow trigger
  • inhalation possible via a mouthpiece, inhalation mask and tracheal cannula

Price (without guarantee)

The price is available on request from the manufacturer / distributor.

Product Information from the Manufacturer / Distributor

Weitere Details des Herstellers als PDF

REHADAT does not sell any products

Please contact the manufacturer or distributor.

Manufacturer

Löwenstein Medical GmbH & Co. KG
Arzbacher Str. 80
56130 Bad Ems
Germany
02603 9600-0
info@loewensteinmedical.com
https://hul.de

Distributor

Sanitätsfachhandel

https://biv-ot.org/ueber_uns/mitglieder/sanitaetshausdatenbank/index_ger.html

Technical Data

Weight: Control unit 75 g / power supply unit 165 g
Dimensions (H x D x W): 85 x 54 x 16 mm
Supply: Internal: 3.6 V / 500 mA External: 5V/1.2A
Power consumption during company: 500 mA Maximum
Nebulizer output: < 0.6 ml/min
Power supply unit Cable length: 1.8 m
Max. Filling quantity nebulizer unit: 8 ml
Battery type: Lithium-ion, 3.7 V / 1200 mAh
Battery charging time: approx. 3 hours

ICF Items

Reference Number:

Hil132661


Last Update: 5 Jul 2024